Tornado Global Hydrovacs Reports First Quarter 2018 Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
14
Tornado Global Hydrovacs Reports First Quarter 2018 Results

CALGARY, Alberta, May 22, 2018 (GLOBE NEWSWIRE) -- Tornado Global Hydrovacs Ltd. (“Tornado” or the “Company”) (TSX-V: TGH ) today reported its unaudited condensed consolidated financial results for the Three Months ended March 31, 2018. The unaudited condensed consolidated financial statements and MD&A have been filed on SEDAR and can be reviewed at www.sedar.com . 

Financial and Operating Highlights (in CAD $000’s except per share data)

         
        Three Months ended March 31    
        2018     2017    
           
  Revenue   $ 4,831   $5,989    
  Cost of sales       3,943       5,092    
  Gross Profit       888       897    
           
  Selling and general administrative expenses       1,244       973    
  Depreciation and amortization       256       256    
  Stock-based compensation       68       -     
  Net finance income and other       (1 )     (10 )  
           
  Loss before tax       (679 )     (322 )  
  Income tax recovery       44       -     
           
  Net loss   ($ 635 ) ($322 )  
  Net loss per share - basic and diluted     $ -   $(0.01 )  
           
  EBITDAS (1)   ($ 356 ) ($76 )  
  EBIT (1)   ($ 684 ) ($332 )  
           
  Total assets   $ 23,049   $19,014    
  Shareholders Equity   $ 17,573   $13,037    
                   

 

Three months ended March 31, 2018

  • Revenue of $4,831 decreased 19.3% compared to $5,989 in Q1/2017. The decrease in revenue was due to a delay in completion and delivery of hydrovac trucks during the quarter. Three completed trucks held in inventory as at March 31, 2018 were delivered and sold in early Q2 2018.  
  • Despite the decreased revenue, Gross Profit of $888 was comparable to $897 in the same period of 2017 due to production efficiencies at the company’s Stettler plant.  
  • Selling and general and administrative expenses of $1,244 increased by $271 compared to $973 in the same period of 2017. The increase is principally due to increased employee costs of the North America operation and increased overhead costs of the China operation and corporate.  
  • EBITDAS (1) of negative $356, comprising North America ($96), China (negative $287) and Corporate (negative $165), decreased by $280 compared to negative $76 in Q1/2017, due to increased selling and general and administrative expenses. For the North America segment, EDITDAS during the quarter of $96 decreased significantly compared to Q4 2017, due to decreased activity levels. For China, negative EDITDA during the quarter was ($287) and is expected to stay at this level until there is an increase in the scope of operations.      
  • Net loss of $635 increased by $313 compared to a loss of $322 in Q1/2017. This is due to the factors discussed above, together with stock-based compensation expense of $68.

1 Earnings (loss) before interest, tax, depreciation, amortization and stock-based compensation (EBITDAS) and Earnings (loss) before interest and tax (EBIT) are not defined by IFRS. The definition of EBITDAS does not consider gains and losses on the disposal of assets, fair value changes in foreign currency forward contracts and non-cash components of stock-based compensation. While not an IFRS measure, EBITDAS is used by management, creditors, analysts, investors and other financial stakeholders to assess the Group’s performance and management from a financial and operational perspective.

Segmented information (in CAD $000’s)

           
Three Months ended March 31, 2018 North America China   Corporate   Total    
Revenue $4,831   $ -     $ -   $4,831    
Cost of sales      3,943     -       -     3,943    
Selling and general administrative      792     287       165     1,244    
EBITDAS $96 ($287 ) ($165 ) ($356 )  
           
           
Three Months ended March 31, 2017 North America China   Corporate   Total    
Revenue $5,989   $ -     $ -   $5,989    
Cost of sales      5,092     -       -     5,092    
Selling and general administrative      560     223       190     973    
EBITDAS $337 ($223 ) ($190 ) ($76 )  
 

Outlook

The market demand in North America from the municipal sectors in both Canada and United States is expected to stay strong during 2018. The Company is also benefiting from increased demand because of the significant design improvements of its hydrovac trucks. The Company continues to develop its relationship with its US partner and expects revenue growth in the 2 nd half of 2018. As a result, the Company expects strong financial performance in North America.

In China, the Company continues to execute its business plan to capitalize on this significant market opportunity. By the end of Q2 2018, the Company expects to have four unique products for demonstration and potential future revenue. As a result of these factors management believes the Company’s medium and long-term outlook is positive in China.

About Tornado Global Hydrovacs Ltd.

The Company designs and manufactures hydrovac trucks in Canada and sells hydrovac trucks for excavation service providers to the oil and gas industry and the municipal markets in Canada and the USA. Hydrovac trucks use high pressure water to pulverize soil and turn it into mud, and then vacuum up the resulting mud into its tank. Tornado currently operates in North America. The Company intends to expand its hydrovac business into China and has established a wholly owned operation in China with a head office in Beijing. 

For more information about Tornado Global Hydrovacs Ltd., visit www.tornadotrucks.com  or contact:

Bill Rollins Chief Executive Officer Phone: (403) 204-6333 Email:  brollins@tghl.ca

Al Robertson Chief Financial Officer Phone: (403) 204 -6363 Email: arobertson@tghl.ca

Advisory

Neither the Exchange nor its Regulation Service Provider (as that term is defined in policies of the Exchange) accepts responsibility for the adequacy or accuracy of this news release

Certain statements contained in this news release constitute forward-looking statements. These statements relate to future events. All statements other than statements of historical fact are forward-looking statements. The use of the words ‘‘may”, “expects”, “expected”, “believes”, “anticipates” and other words of a similar nature are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Although the Company believes these statements to be reasonable, no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. Such statements include statements regarding the Company’s outlook for the rest of the year and the anticipated demand for the Company’s newly designed hydrovac truck.   Actual results could differ materially from those anticipated in these forward-looking statements as a result of prevailing economic conditions, receipt of requisite regulatory approvals, and other factors, many of which are beyond the control of the Company.  The forward-looking statements contained in this news release represent the Company’s expectations as of the date hereof, and are subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as may be required by applicable securities regulations.

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 104

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Decibel's Export Engine Masks a Domestic Sales Slip

Updated Category News Views 73

Decibel’s overseas business is doing the heavy lifting, and it is not doing it quietly. Third-quarter net revenue reached $35.1 million, up 7% from a year earlier, while international sales jumped 44% to a record $12.1 million. That split matters more than the headline. Canadian adult-use sales fell 6% to $23.0 million, which means the company is proving it can find...

Continue Reading
Brightstar Picks Warsop for Its Next CEO Chapter Ahead

Updated Category News Views 99

A Handoff With Plenty Riding on the Rails A lottery supplier changing captains is not usually fireworks, but this one deserves a hard look. Brightstar Lottery has named Thomas Warsop to replace Vince Sadusky as chief executive officer and board member effective January 1, 2027. Sadusky is retiring from both posts on that date. The company is telegraphing an orderly baton...

Continue Reading
Winter Leaks Can Lock In Tarrant Sewer Costs for 2027

Updated Category News Views 86

Silent toilet seepage has a nasty habit of turning winter into a twelve-month utility hangover. Tarrant County homeowners are heading into the period when some local cities use household water consumption to calculate residential sewer charges for the following year. That is not the sort of detail anybody enjoys thinking about during the holidays, but ignoring it can be...

Continue Reading
Rare Stellar Merger Validates RIT Theory in Nature

Updated Category News Views 82

One star swallowed another’s orbit, and astronomy finally caught the evidence. That is the plain-English punch of the observation called AT 2025abao in the Andromeda Galaxy, and it is a meaningful one for Jason Nordhaus and his colleagues at Rochester Institute of Technology. On Nov. 18, research published in Nature validated a scenario Nordhaus’s team had predicted...

Continue Reading
Tigerlily Takes Its Advocacy Model to Ovarian Cancer

Updated Category News Views 90

Ovarian cancer has a nasty habit of hiding behind symptoms people are taught to shrug off. Persistent bloating or pelvic pain can look like any number of ordinary problems, and that ambiguity is exactly why practical, trusted education matters. Tigerlily Foundation's new ovarian cancer initiative is not a flashy breakthrough claim. It is a grounded attempt to help women...

Continue Reading
OFRM Recall Leaves Investors Facing Hard Questions

Updated Category News Views 22

Nothing wrecks a young consumer brand’s glow faster than a recall involving toddlers, and Once Upon A Farm has just learned that lesson in the ugliest possible way. On November 2, 2026, shares of NYSE:OFRM fell 37% to close at $9.44. That left the stock roughly 47% below its $18 IPO price. Those are not the garden-variety bruises of a weak quarter. That is the market...

Continue Reading
Century Lithium Clears a Crucial Nevada Permit Gate

Updated Category News Views 24

Permitting news rarely rings a cash register, but it can stop one from being bolted shut. Century Lithium has received confirmation from the Bureau of Land Management’s Tonopah Field Office that baseline studies for its wholly owned Angel Island lithium project in Esmeralda County, Nevada, are complete. The agency also set the project on the Environmental Impact...

Continue Reading
GFT's Banking Leader Tag Puts Execution Risks Into Focus

Updated Category News Views 82

A banking overhaul is where glossy slides go to die. That is why GFT Technologies being named a Leader in QKS Group's 2026 SPARK Matrix for Digital Banking Services deserves a little more attention than the usual analyst-firm trumpet blast. This is not a prize for making a pretty mobile app. The work described here runs through strategy, architecture, core-platform...

Continue Reading
HLRBO's Data-Heavy Rebuild Changes Hunting Lease Market

Updated Category News Views 95

A hunting lease used to begin with hearsay, blurry photos, and a whole lot of hoping. HLRBO is trying to drag that stubbornly analog process into a data-rich, phone-first marketplace, and frankly, it is about time. The company rebuilt its web and mobile platforms around parcel information, plain-language AI search, mobile lease completion, and its Land IQ™ scoring...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights from the Global MOOC Conference on Future Education Trends

Updated Category News Views 197

The 2025 Global MOOC and Online Education Conference Overview The 2025 Global MOOC and Online Education Conference took place at the National Autonomous University of Mexico (UNAM) and focused on the theme of breaking boundaries to reshape futures in education. This event gathered educators and leaders in the field to discuss the future of online learning, with a...

Continue Reading
Truist Securities Predicts Growth Surge for Amazon Stock

Updated Category News Views 105

Amazon.com Inc (NASDAQ: AMZN) caught the attention of traders when Truist Securities boosted its price target from $230 to $265 back in early 2024. This wasn’t just a haphazard bump; they backed it with analysis that showed Amazon’s North American revenue holding steady, proving that consumers still love their Prime subscriptions and shopping sprees. What's fueling...

Continue Reading
Exploring the Rise of Probiotics in Animal Nutrition Market

Updated Category News Views 217

Understanding the Growth of Probiotics in Animal Feed As the demand for sustainable and antibiotic-free farming practices increases, the global probiotics in animal feed market is experiencing remarkable growth. Recent projections indicate that this market is expected to rise significantly, reflecting a shift in agricultural practices aimed at enhancing animal health and...

Continue Reading
Ascidian Therapeutics Announces Key Appointment to Advance Eyecare

Updated Category News Views 324

Key Appointment and New Advisory Board at Ascidian Therapeutics Ascidian Therapeutics, a pioneering biotechnology company focused on rewriting RNA to combat human diseases, has made a significant announcement. They have appointed Dr. Murray A. Abramson as Chief Development Officer (CDO) and created an Ophthalmology Clinical Advisory Board. This strategic move aims to...

Continue Reading
Waymo's Latest Robotaxi Innovation Marks a New Self-Driving Era

Updated Category News Views 375

Waymo's New Robotaxi Launches with Advanced Self-Driving Features Alphabet Inc.'s autonomous ride-hailing company, Waymo, has taken a significant step by introducing its latest Robotaxi equipped with sixth-generation self-driving technology. This advanced vehicle is now undergoing rigorous testing to ensure its readiness for the ever-competitive self-driving market....

Continue Reading